Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Paired-Box (PAX) Gene Signatures as a Biomarker of Breast Cancer Progression. | Int J Mol Sci | 2026 | 41752124 | PubTator, text mining | PubMed |
| Lactate metabolism and protein lactylation in cancer. | Mol Biomed | 2026 | 41746580 | PubTator, text mining | PubMed |
| miR-940 suppresses ferroptosis by controlling expression of key regulatory genes. | bioRxiv | 2026 | 41726925 | PubTator, text mining | PubMed |
| Histopathological and Molecular Characteristics of Pediatric Adrenocortical Tumors: where Do we Stand? | Endocr Pathol | 2026 | 41712100 | PubTator, text mining | PubMed |
| Dysregulated expression of cell cycle regulators CDC20, PLK1, BUB1, CDC45, CDCA5 in pancreatic ductal adenocarcinoma. | Sci Rep | 2026 | 41699006 | PubTator, text mining | PubMed |
| Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma. | Cell Oncol (Dordr) | 2026 | 41697437 | PubTator, text mining | PubMed |
| Tumor cell cycle regulation: integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies. | Mol Biomed | 2026 | 41692895 | PubTator, text mining | PubMed |
| BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer. | Sci Rep | 2026 | 41673219 | PubTator, text mining | PubMed |
| Telomere-based Risk Model for Prognosis Prediction in Clear Cell Renal Cell Carcinoma. | Curr Med Chem | 2026 | 41620921 | PubTator, text mining | PubMed |
| Exploring the mechanism and therapeutic potential of BUB1 in regulating esophageal cancer progression based on 5-FU target prediction. | Discov Oncol | 2026 | 41618008 | PubTator, text mining | PubMed |
| A system-level metastable model of cancer evolution: integrating replication stress, cell cycle deregulation and chromosomal instability. | Ann Med | 2026 | 41606986 | PubTator, text mining | PubMed |
| Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial. | Nat Commun | 2026 | 41593097 | PubTator, text mining | PubMed |
| The role of HMGA1 in genome stability: Implications in human cancer. | Cell Mol Life Sci | 2026 | 41586900 | PubTator, text mining | PubMed |
| Focal Adhesion and Cancer Cell Cycle-Associated Resistance. | ACS Omega | 2026 | 41552449 | PubTator, text mining | PubMed |
| Unraveling lipedema: comprehensive insights and the path to future discoveries. | NPJ Metab Health Dis | 2026 | 41548036 | PubTator, text mining | PubMed |
| Identification of hub genes and construction of a survival prediction model for patients with nasopharyngeal carcinoma. | Sci Rep | 2026 | 41545643 | PubTator, text mining | PubMed |
| Translational evaluation of BUB1B as a precision medicine biomarker for hepatocellular carcinoma. | Sci Rep | 2026 | 41545558 | PubTator, text mining | PubMed |
| Development of a split-toxin CRISPR screening platform to systematically identify regulators of human myoblast fusion. | Nat Commun | 2026 | 41540035 | PubTator, text mining | PubMed |
| Linking kinetochore attachment to checkpoint control: the role of Aurora B in BubR1 acetylation. | Nucleic Acids Res | 2026 | 41533580 | PubTator, text mining | PubMed |
| A comprehensive study integrating bioinformatics analysis and experimental results on HROB as a potential biomarker for the prognosis of lung adenocarcinoma. | Sci Rep | 2026 | 41526502 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=3